Stoke Therapeutics, Inc. (STOK) Free cash flow 2018–2025
Stoke Therapeutics, Inc. (STOK) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
$44.9MFY2025 · since FY2018: -$11.9M → $44.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $44.9M | +151.6% |
| FY2024 | -$87.1M | -5.3% |
| FY2023 | -$82.7M | -130.8% |
| FY2022 | -$35.8M | +47.4% |
| FY2021 | -$68.1M | -57.4% |
| FY2020 | -$43.3M | -32.4% |
| FY2019 | -$32.7M | -174.7% |
| FY2018 | -$11.9M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice